Shenkang injection improves chronic kidney disease by inhibiting multiple renin-angiotensin system genes by blocking the Wnt/β-catenin signalling pathway

Chronic kidney disease (CKD) is a major worldwide public health problem. The increase in the number of patients with CKD and end-stage kidney disease requesting renal dialysis or transplantation will progress to epidemic proportions in the next several decades. Although blocking the renin-angiotensi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yan-Ni, Liu, Hong-Jiao, Ren, Li-Li, Suo, Ping, Zou, Liang, Zhang, Ya-Mei, Yu, Xiao-Yong, Zhao, Ying-Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9432462/
https://www.ncbi.nlm.nih.gov/pubmed/36059935
http://dx.doi.org/10.3389/fphar.2022.964370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9432462/
https://www.ncbi.nlm.nih.gov/pubmed/36059935
http://dx.doi.org/10.3389/fphar.2022.964370

Ejemplares similares